The results unveiled a significant reduction in HIF-1α expression in the T2DM group, subsequently restored with FG-4592 pretreatment, indicating FG-4592’s ability to stabilize HIF-1α expression in the of T2DM mice under relative hypoxia conditions (Fig. 3a–e). This evidence concerns the gene HIF1A and type 2 diabetes mellitus.